ACT Advisors »

Rani Therapeutics Hldgs shares owned by ACT Advisors

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by ACT Advisors from 13F filings

Historical chart of ACT Advisors investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by ACT Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by ACT Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.4k 15k 0.50

More positions owned by ACT Advisors

Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
American Centy Etf Tr Intl Eqt Etf (AVDE)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Ishares Tr Core S&p500 Etf (IVV)
Capital Group Dividend Value Shs Creation Uni (CGDV)
New York Life Invts Active E Nyli Mackay Muni (MMIN)
Vaneck Etf Trust Fallen Angel Hg (ANGL)
Spdr Series Trust Portfolio Agrgte (SPAB)
Spdr Series Trust Nuveen Ice Munic (TFI)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Series Trust Portfolio S&p500 (SPLG)
Ishares Tr Msci Usa Min Vol (USMV)
J P Morgan Exchange Traded F Betabuilders Us (BBAG)

View all positions for ACT Advisors

Top funds holding Rani Therapeutics Hldgs

Vanguard Group
Nan Fung Group Holdings
Citadel Advisors
United Services Automobile Association
Geode Capital Management
Kestra Private Wealth Services
Takeda Pharmaceutical
CWA Asset Management
BlackRock
Hrt Financial
Northern Trust
UBS Group
Marc Lasry
State Street Corporation
Luther King Capital Management Corporation

View all funds holding Rani Therapeutics Hldgs